======= C8orf4 ======= == Gene Information == * **Official Symbol**: TCIM * **Official Name**: transcriptional and immune response regulator * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=56892|56892]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NR00|Q9NR00]] * **Interactions**: [[https://thebiogrid.org/search.php?search=C8orf4&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20C8orf4|Open PubMed]] * **OMIM**: [[https://omim.org/entry/607702|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Seems to be involved in the regulation of cell growth an differentiation, may play different and opposite roles depending on the tissue or cell type. May enhance the WNT-CTNNB1 pathway by relieving antagonistic activity of CBY1 (PubMed:16424001, PubMed:16730711). Enhances the proliferation of follicular dendritic cells (PubMed:16730711). Plays a role in the mitogen- activated MAPK2/3 signaling pathway, positively regulates G1-to-S- phase transition of the cell cycle (PubMed:18959821). In endothelial cells, enhances key inflammatory mediators and inflammatory response through the modulation of NF-kappaB transcriptional regulatory activity (PubMed:19684084). Involved in the regulation of heat shock response, seems to play a positive feedback with HSF1 to modulate heat-shock downstream gene expression (PubMed:17603013). Plays a role in the regulation of hematopoiesis even if the mechanisms are unknown (By similarity). In cancers such as thyroid or lung cancer, it has been described as promoter of cell proliferation, G1-to-S-phase transition and inhibitor of apoptosis (PubMed:15087392, PubMed:24941347). However, it negatively regulates self-renewal of liver cancer cells via suppresion of NOTCH2 signaling (PubMed:25985737). {ECO:0000250|UniProtKB:Q9D915, ECO:0000269|PubMed:15087392, ECO:0000269|PubMed:16424001, ECO:0000269|PubMed:16730711, ECO:0000269|PubMed:17603013, ECO:0000269|PubMed:18959821, ECO:0000269|PubMed:19684084, ECO:0000269|PubMed:24941347, ECO:0000269|PubMed:25985737, ECO:0000305}. No Pfam Domain information is available for this gene. |endothelial cell activation involved in immune response| |positive regulation of protein kinase C activity| |regulation of protein kinase C activity| |positive regulation of protein kinase A signaling| |endothelial cell activation| |regulation of protein kinase A signaling| |Notch binding| |negative regulation of Notch signaling pathway| |cellular response to heat| |positive regulation of NIK/NF-kappaB signaling| |regulation of Notch signaling pathway| |regulation of NIK/NF-kappaB signaling| |response to heat| |regulation of DNA-templated transcription in response to stress| |regulation of cell cycle G1/S phase transition| |response to temperature stimulus| |positive regulation of protein serine/threonine kinase activity| |nuclear speck| |regulation of cell cycle phase transition| |regulation of hemopoiesis| |regulation of protein serine/threonine kinase activity| |positive regulation of protein kinase activity| |positive regulation of kinase activity| |cell activation involved in immune response| |positive regulation of transferase activity| |regulation of cell cycle process| |regulation of protein kinase activity| |nucleolus| |regulation of kinase activity| |negative regulation of apoptotic process| |negative regulation of programmed cell death| |apoptotic process| |regulation of transferase activity| |negative regulation of cell death| |positive regulation of protein phosphorylation| |positive regulation of intracellular signal transduction| |programmed cell death| |positive regulation of phosphorylation| |cell activation| |cell death| |immune effector process| |positive regulation of phosphate metabolic process| |positive regulation of phosphorus metabolic process| |response to abiotic stimulus| |regulation of cell cycle| |positive regulation of protein modification process| |negative regulation of signal transduction| |negative regulation of cell communication| |negative regulation of signaling| |positive regulation of catalytic activity| |regulation of protein phosphorylation| |regulation of apoptotic process| |regulation of programmed cell death| |regulation of phosphorylation| |positive regulation of cellular protein metabolic process| |negative regulation of response to stimulus| |regulation of immune system process| |positive regulation of signal transduction| |regulation of cell death| |cellular response to stress| |positive regulation of protein metabolic process| |positive regulation of molecular function| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |regulation of protein modification process| |immune response| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp225|Celastrol 0.12μM R05 exp225]]|-1.81| |[[:results:exp224|CB-839 10μM R05 exp224]]|-1.71| |[[:results:exp435|JQ1 0.8μM R08 exp435]]|1.98| ^Gene^Correlation^ |[[:human genes:h:hgc6.3|HGC6.3]]|0.627| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 14205 * **Expression level (log2 read counts)**: -5.28 {{:chemogenomics:nalm6 dist.png?nolink |}}